Insider Buying Spurs Bullish Signal for ANIXA Biosciences
Insider buying heats up ANIXA BIOSCIENCES—Titterton Lewis H. Jr. buys 8,000 shares at $2.98 amid a 12.26% weekly gain, 30.9% YTD volatility, and rising buzz.
3 minutes to read
ANIXA BIOSCIENCES INC
CEO Kumar Amit Buys 7,000 Anixa Shares—Signal of Growing Investor Confidence
CEO Kumar Amit’s latest 7,000‑share purchase at $2.78 shows growing confidence in Anixa Biosciences’ cancer‑diagnostics pipeline, hinting at future upside.
4 minutes to read
Insider Buys at Anixa Biosciences Signal Management Confidence & Potential Upside
Insider buys at Anixa Biosciences show management confidence amid valuation dips, hinting at a possible near‑term rebound for the oncology diagnostics stock.
3 minutes to read
CEO Buys More Anixa Shares Amid Volatile Prices—Is It a Signal of Future Upside?
Insider buying at Anixa Biosciences (ANXB) shows CEO confidence amid a 21.9% decline; explore the risks and upside of its CAR‑T and vaccine pipeline.
4 minutes to read